Literature DB >> 7870680

Effects of protease inhibitors on vasopressin transport across rat alveolar epithelial cell monolayers.

H Yamahara1, K Morimoto, V H Lee, K J Kim.   

Abstract

The transepithelial transport of arginine vasopressin (AVP) across cultured rat alveolar epithelial cell monolayers was studied. At 0.1 nM donor [125I]AVP, the radiolabel flux measured in the apical-to-basolateral (AB) direction was about 10 times greater than that in the reverse (BA) direction. HPLC analyses of the basolateral receiver fluid collected at the end of these flux measurements showed that about 97% of the total [125I]label represented subspecies of AVP, whereas the apical receiver fluid contained largely intact AVP (approximately 85% of total [125I]label). Both donor fluids contained virtually no degradation products of AVP (> 99%). In the presence of an excess 0.1 mM unlabeled AVP in the apical donor fluid, the Papp for radiolabeled AVP in the AB direction was decreased by approximately 68%, while the fraction of intact AVP in the basolateral receiver fluid was increased six-fold as compared to that observed at 0.1 nM [125I]AVP alone. Under this condition, the flux of intact AVP was approximately the same in both directions. When the concentration of apical camostat mesylate, an aminopeptidase inhibitor, was varied from 0 to 2 mM, the radiolabeled flux in the AB direction (with 0.1 nM [125I]AVP in the donor fluid) was significantly decreased in a dose-dependent manner, yielding commensurably elevated concentrations of intact AVP in the basolateral receiver fluid. In contrast, leupeptin (0.5 mM), a serine protease inhibitor, was without effect. These data, taken together, suggest that apically-presented AVP undergoes proteolysis (most likely by peptidases localized at apical cell membranes of alveolar epithelium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870680     DOI: 10.1023/a:1018918022865

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Effects of enzymatic inhibition and increased paracellular shunting on transport of vasopressin analogues in the rat.

Authors:  A L Ungell; A Andreasson; K Lundin; L Utter
Journal:  J Pharm Sci       Date:  1992-07       Impact factor: 3.534

2.  Biliary excretion of the vasopressin analogue DDAVP after intraduodenal, intrajugular and intraportal administration in the conscious pig.

Authors:  S Lundin; S G Pierzynovski; B R Weström; H I Bengtsson
Journal:  Pharmacol Toxicol       Date:  1991-03

3.  p146 type II alveolar epithelial cell antigen is identical to aminopeptidase N.

Authors:  J D Funkhouser; S D Tangada; M Jones; S J O; R D Peterson
Journal:  Am J Physiol       Date:  1991-04

4.  Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology.

Authors:  J B van Bree; S Tio; A G de Boer; M Danhof; J C Verhoef; D D Breimer
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

5.  Antidiuretic response in conscious dogs following peroral administration of arginine vasopressin and its analogues.

Authors:  H Vilhardt; P Bie
Journal:  Eur J Pharmacol       Date:  1983-09-30       Impact factor: 4.432

6.  Dipeptide transport across rat alveolar epithelial cell monolayers.

Authors:  K Morimoto; H Yamahara; V H Lee; K J Kim
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

7.  In vitro degradation of some arginine-vasopressin analogs by homogenates of rat kidney, liver and serum.

Authors:  Z Grzonka; F Kasprzykowski; L Lubkowska; K Darłak; T A Hahn; A F Spatola
Journal:  Pept Res       Date:  1991 Sep-Oct

8.  Contribution of active Na+ and Cl- fluxes to net ion transport by alveolar epithelium.

Authors:  K J Kim; J M Cheek; E D Crandall
Journal:  Respir Physiol       Date:  1991-08

9.  Degradation of radiolabelled arginine vasopressin (125I-AVP) by the human placenta perfused in vitro.

Authors:  M J Landon; D K Copas; E A Shiells; J M Davison
Journal:  Br J Obstet Gynaecol       Date:  1988-05

10.  Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine.

Authors:  P Krugliak; D Hollander; T Y Ma; D Tran; V D Dadufalza; K D Katz; K Le
Journal:  Gastroenterology       Date:  1989-11       Impact factor: 22.682

View more
  5 in total

1.  Systematic investigations of the influence of molecular structure on the transport of peptides across cultured alveolar cell monolayers.

Authors:  A N Dodoo; S Bansal; D J Barlow; F C Bennet; R C Hider; A B Lansley; M J Lawrence; C Marriott
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

2.  Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.

Authors:  Leena N Patel; Jeffrey Wang; Kwang-Jin Kim; Zea Borok; Edward D Crandall; Wei-Chiang Shen
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

Review 3.  Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes.

Authors:  Maliheh Ghadiri; Paul M Young; Daniela Traini
Journal:  Pharmaceutics       Date:  2019-03-11       Impact factor: 6.321

4.  Pulmonary delivery of an ultra-fine oxytocin dry powder formulation: potential for treatment of postpartum haemorrhage in developing countries.

Authors:  Richard J Prankerd; Tri-Hung Nguyen; Jibriil P Ibrahim; Robert J Bischof; Gemma C Nassta; Livesey D Olerile; Adrian S Russell; Felix Meiser; Helena C Parkington; Harold A Coleman; David A V Morton; Michelle P McIntosh
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

5.  Development of new in vitro models of lung protease activity for investigating stability of inhaled biological therapies and drug delivery systems.

Authors:  Arcadia Woods; Teodora Andrian; Gemma Sharp; Elif Melis Bicer; Kalliopi-Kelli A Vandera; Ayasha Patel; Ian Mudway; Lea Ann Dailey; Ben Forbes
Journal:  Eur J Pharm Biopharm       Date:  2019-11-20       Impact factor: 5.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.